glp 1 aafp Glucagon-Like Peptide-1 Receptor Agonists for People With Chronic Kidney Disease and Diabetes FDA Approves First GLP-1 Pill

Trust your gut: Exploring the connection between gut microbiome dysbiosis and the advancement of Metabolic Associated Steatosis Liver Disease (MASLD)/Metabolic Associated Steatohepatitis (MASH): A systematic review of animal and human studies

[Multidrug-resistant bacteria in animals and humans]

If you are breastfeeding now and considering GLP-1 therapy for the future, PlexusDx helps you build a personalized health roadmap

Safety Side Effects & Considerations In the safety department, BPC-157 looks very clean across the preclinical literature

If you take other medications - particularly diabetes medications, thyroid medications, or blood thinners - discuss potential interactions with your assigned clinical provider before starting a GLP-1 program